# High-flow Nasal Cannula Nebulization of Beta 2 Adrenergic Agonist During Acute Exacerbation of Chronic Obstructive Pulmonary Disease

> **NCT03449056** · PHASE3 · UNKNOWN · sponsor: **Poitiers University Hospital** · enrollment: 25 (estimated)

## Conditions studied

- Chronic Obstructive Pulmonary Disease
- High-flow Nasal Cannula

## Interventions

- **DRUG:** salbutamol

## Key facts

- **NCT ID:** NCT03449056
- **Lead sponsor:** Poitiers University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-01-11
- **Primary completion:** 2020-01
- **Final completion:** 2020-04
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2019-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03449056

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03449056, "High-flow Nasal Cannula Nebulization of Beta 2 Adrenergic Agonist During Acute Exacerbation of Chronic Obstructive Pulmonary Disease". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03449056. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*